Vimarsana
Biggest News Aggregation in the World

Page 26 - Science Summit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Science Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Science Summit Today - Breaking & Trending Today

The Falling Walls Science Summit Journalist Fellowship 2023 for Journalists (Fully Funded to Berlin, Germany) - Vimarsana News

The Falling Walls Science Summit Journalist Fellowship 2023 for Journalists (Fully Funded to Berlin, Germany)

The Falling Walls Science Summit Journalist Fellowship 2023 for Journalists (Fully Funded to Berlin, Germany) Application Deadline: 1 September 2023, 23:59

King Describes Unmet Needs and the Role of Surgical Resection in Residual Non-RP Testicular Cancer - Vimarsana News

King Describes Unmet Needs and the Role of Surgical Resection in Residual Non-RP Testicular Cancer

Dr King discusses the need for improved guidance when determining the appropriate management strategy for patients with residual nonretroperitoneal testicular cancer and findings from a study on the association between the presence of teratoma in the primary orchiectomy and the rate of teratoma in this disease.

Short Shares Post-Conference Perspectives in Acute Lymphoblastic Leukemia From ASCO and EHA 2023 - Vimarsana News

Short Shares Post-Conference Perspectives in Acute Lymphoblastic Leukemia From ASCO and EHA 2023

Dr Short discusses data in acute lymphoblastic leukemia that were presented at the 2023 ASCO Annual Meeting and EHA Congress.

Camidge and Cetnar Revisit ASCO 2023 Data in Lung Cancer - Vimarsana News

Camidge and Cetnar Revisit ASCO 2023 Data in Lung Cancer

In this episode of ‘How This is Building Me,’ Dr Camidge is rejoined by Dr Cetnar to discuss the good, the bad, and the ugly of the lung cancer data that were presented at the 2023 ASCO Annual Meeting.

Investigation of Pembrolizumab De-Escalation After pCR Aims to Challenge SOC in Early-Stage TNBC - Vimarsana News

Investigation of Pembrolizumab De-Escalation After pCR Aims to Challenge SOC in Early-Stage TNBC

Yuan Yuan, MD, PhD, discusses the OptimICE-pCR trial and other ongoing clinical trials in breast cancer being conducted at Cedars-Sinai, and expands on the role of CDK4/6 inhibitors and other novel treatment strategies for patients with hormone receptor-positive breast cancer.